In general, current transgenic (tg) AD mouse models are either amyloidosis models, recapitulating only the amyloid β (Aβ) plaque formation from the disease, or tau models, recapitulating only the tau phosphorylation and tangle formation, or multiple tg models combining both pathologies. This evidence concerns the gene MAPT and amyloidosis.